Advokatfirman Vinge houses a ‘highly skilled’ team which is well-known for its expertise in patent disputes concerning royalty agreements, patent assignments, and supplementary protection certificates (SPC). The group frequently assists global pharma and biotech companies, healthcare corporates and investment funds within the life sciences and consumer health sectors. The ‘exceptional’ Stojan Arnerstål leads the team, and maintains a transaction-focused practice, advising on a range of manufacturing, commercialisation and development agreements within the pharma space. Noted for the ‘unrivalled depth’ of his knowledge, Håkan Borgenhäll is an IP specialist who has notable experience in handling contentious matters involving registered designs, marketing issues and trade marks.
Testimonials
Collated independently by Legal 500 research team.
‘Stojan Arnerstål is an exceptional adviser for commercial agreements, providing real value through his pragmatic, business-oriented approach and quick turnarounds in our matters. Excellent management skills.’
‘Vinge's practice provides broad coverage and in-depth knowledge of the sector. They have a solid group of lawyers who are very responsive with a commercial mindset.’
‘Stojan Arnerstål has excellent knowledge and experience of the healthcare and life sciences industry. He is very skilled in conveying legal advice on commercial and complex matters in a practical and engaging way across all areas of the industry.’
‘Great team. Highly skilled. Super court advocates. I have had superb successes with them.’
‘Håkan Borgenhäll has immense experience litigating IP in Sweden. Unrivalled depth of knowledge.’
- ‘Malin Malm Waerme is a younger partner. Creative, super in court, proactive.’
Key clients
- Eli Lilly and Company
- Bridgepoint Growth
- Fidelio Capital
- Recipharm AB
- Atlas Antibodies AB
- Tamro AB
- Vimian Group AB
- Corline Biomedical AB
- Medivir AB
- Xspray Pharma AB
- Hansa Biopharma AB
- Calliditas Therapeutics AB
- Oncopeptides AB
- BioGaia AB
- Nanoform Finland Plc
- Medicover AB
- Järven Plast & Smide Aktiebolag
- Cinclus Pharma
- A3P Biomedical
- Healthcap
- Attgeno AB
Work highlights
- Representing Latvia MGI Tech SIA, MGI Tech Hong Kong Co., Ltd. and MGI International Sales Co., Ltd in 12 patent disputes where the counterpart is Illumina, a US company.
- Represented Hansa Biopharma in an arbitration related to a patent assignment and royalty agreement and the request for royalties from certain researchers. The matter included complex interpretation of patent assignment and licensing agreements, including interpretation of the scope of protection of multiple patents.
- Represented Attgeno in connection with an appeal to the Swedish Information Practices Committee (NBL). The matter concerned whether a paid article published by the company in collaboration with a newspaper was to be considered permitted scientific information regarding a certain medical condition, or whether the article was to be considered as unlawful pre-launch advertising of a not-yet approved pharmaceutical.
Practice head
The lawyer(s) leading their teams.
Stojan Arnerstål